Several studies examined O-6-methylguanine-DNA methyltransferase (MGMT) methylation, codeletion of chromosome arms 1p and 19q, and isocitrate dehydrogenase (IDH) mutations to provide insight into LGG pathogenesis and advance cancer therapies for patients with LGGs [3, 4]. This evidence concerns the gene MGMT and cancer.